To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process.

4 steps remain before this bill could become law.

The record's latest action, on May 22, 2015: Referred to the Subcommittee on Health.

1. Clearing the committees it was referred to, and being scheduled for a floor vote
2. Passage by the House
3. Passage by the Senate
4. The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.

Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.

In the 114th Congress (2015-16), 329 of the 10,233 bills and joint resolutions introduced became law, about 3.2 percent. That count covers every measure at every stage, including the many that never left committee.

This one is not there yet: 4 steps are still outstanding, listed above.

No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.

A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.

JOHN SHIMKUS (R-IL) introduced it on May 19, 2015. No cosponsors are recorded.

Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.

It was introduced on May 19, 2015, 4132 days ago. The most recent recorded action was 4129 days ago, on May 22, 2015.

Measures do not carry over. Anything the 114th Congress has not finished by January 3, 2017 dies when the term ends, and has to be introduced again from the start in the next Congress.